• Explore /
  • Poster
  • / Phase 2 trial of TRC102 (methoxyamine HCl) with temozolomide (TMZ) in patients with granulosa cell ovarian cancer.

Phase 2 trial of TRC102 (methoxyamine HCl) with temozolomide (TMZ) in patients with granulosa cell ovarian cancer.

Abstract Poster

Authors

null

Sarah Shin

Developmental Therapeutics Clinic/Early Clinical Trials Development Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD

Sarah Shin , Geraldine Helen O'Sullivan Coyne , Jennifer Zlott , Mohamad Adham Salkeni , Naoko Takebe , Ning Ma , Larry V. Rubinstein , Richard Piekarz , Deborah Wilsker , Katherine V. Ferry-Galow , Brandon Miller , Ralph E. Parchment , Shahanawaz Jiwani , Lamin Juwara , Andrea Voth , James H. Doroshow , Alice P. Chen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT01851369

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5564)

DOI

10.1200/JCO.2023.41.16_suppl.5564

Abstract #

5564

Poster Bd #

259

Abstract Disclosures

Similar Posters

First Author: Robert S. Meehan

First Author: Paul James Mulholland

First Author: David D. Tran

First Author: Panagiotis A. Konstantinopoulos